Cangrelor reduces the risk of ischemic complications in patients with single-vessel and multi-vessel disease undergoing percutaneous coronary intervention: Insights from the CHAMPION PHOENIX trial
Keywords: استفاده جهانی از استرپتوکیناز و پلاسمینوژن بافتی برای آئورت های عروق کرونر; ACS; acute coronary syndromes; CABG; coronary artery bypass grafting; CI; confidence interval; GUSTO; Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries; IDR; ischemia-driven revascularization; MI; myocardi